Psomagen, Inc. (KOSDAQ:950200)
South Korea · Delayed Price · Currency is KRW 2,990.00
+30.00 (1.01%)
At close: Aug 11, 2026
Psomagen Market Cap
Psomagen has a market cap or net worth of 57.52 billion as of August 11, 2026. Its market cap has decreased by -20.37% in one year.
Market Cap
57.52B
Enterprise Value
56.46B
Revenue
60.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,990.00
ChartMarket Cap Chart
Since July 13, 2020, Psomagen's market cap has decreased from 254.61B to 57.52B, a decrease of -77.41%. That is a compound annual growth rate of -21.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 57.52B | -22.94% |
| Dec 30, 2025 | 74.64B | -4.20% |
| Dec 30, 2024 | 77.91B | -20.59% |
| Dec 28, 2023 | 98.10B | -34.17% |
| Dec 29, 2022 | 149.03B | -12.38% |
| Dec 30, 2021 | 170.10B | -50.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| QuadMedicine | 70.04B |
| IMGT Co.,Ltd. | 68.33B |
| PanGen Biotech | 67.84B |
| AriBioLab | 67.51B |
| NovMetaPharma | 64.72B |
| KoBioLabs | 64.37B |
| J2KBIO | 61.75B |
| Naturalendo Tech | 60.15B |